Restatement of Previously Issued Financial Statements (Tables)

3 Months Ended

Mar. 31, 2018

Accounting Changes and Error Corrections [Abstract]

Schedule of financial statements

	March 31, 2018
	As Restated			Adjustments			As Previously Reported
Prepaid expenses and other assets		969,963			464,879			505,084
Total current assets		12,234,278			464,879			11,769,399
Property, plant and equipment, at cost net of accumulated depreciation		1,940,263			(1,088,803	)		3,029,066
Patents		3,107,607			(1,786,863	)		4,894,470
Total other assets		11,109,706			(1,786,863	)		12,896,569
Total assets	$	112,326,496		$	(2,410,786	)	$	114,737,282
Accrued expenses		1,926,676			(1,340,599	)		3,267,275
Derivative and other fair value liabilities		11,469,171			288,824			11,180,347
Total current liabilities		37,672,609		$	(1,051,775	)		38,724,384
Lease payable		1,288,709			1,288,709			-
Total long term liabilities		102,355,090			1,288,709			101,066,381
Total liabilities		140,027,699			236,935			139,790,764
Preferred Series E stock, cumulative, stated value $100 per share, par value $.001, 300,000 shares authorized, 223,950 and 300,000 shares issued and outstanding, respectively		2,696,523			19,631			2,676,892
Common stock, par value $.025, 75,000,000 shares authorized, 2,148,080 and 1,832,372 shares issued and 2,141,393 and 1,830,969 shares outstanding, respectively		33,724			(395,575	)		429,299
Common stock to be issued		4,935			(34,544	)		39,479
Treasury stock, at cost, 11,500 shares		(28,031	)		196,219			(224,250	)
Additional paid in capital		59,699,040			4,159,640			55,539,399
Accumulated equity (deficit)		(92,728,320	)		(4,481,142	)		(88,247,178	)
Total shareholders' equity/deficit		(31,749,141	)		(555,402	)		(31,193,739	)
Noncontrolling interest		1,351,415			(2,111,950	)		3,463,365
Total equity (deficit)		(30,397,726	)		(2,667,352	)		(27,730,374	)
Total liabilities and shareholders' equity	$	112,326,496		$	2,410,786		$	114,737,282

	March 31, 2018
	As Restated			Adjustments			As Previously Reported
Depreciation and amortization		385,986			(46,494	)		432,480
Selling, general and administrative		3,813,431			204,290			3,609,142
Total costs and expenses		5,773,139			157,796			5,615,343
Unrealized gain (loss) on change in fair value of derivative and other fair value liabilities		(1,926,013	)		(4,234,195	)		2,316,360
Interest expense		(320,072	)		(18,343	)		(301,729	)
Total other income (expense)		(2,208,724	)		(4,252,538	)		2,043,813
Loss before income taxes		(7,193,645	)		(4,410,334	)		(2,783,312	)
Provision for income taxes		-						-
Loss from continuing operations		(7,193,645	)		(4,410,334	)		(2,783,312	)
Consolidated Net Loss		(7,737,790	)		(4,410,334	)		(3,327,456	)
Net (gain) loss attributable to noncontrolling interest		(71,064	)		70,808			(141,872	)
Net loss available to common shareholders	$	(7,666,726	)	$	(4,481,142	)	$	(3,185,584	)
Earnings per common share (basic and diluted):
Loss from continuing operations	$	(4.91	)	$	(2.03	)	$	(2.88	)
Loss from discontinued operations	$	(0.25	)	$	-		$	(0.25	)
Net loss per common share	$	(5.16	)	$	(2.03	)	$	(3.13	)
Weighted average number of shares outstanding
(Basic and Diluted)		2,169,861			2,169,861			2,169,861

	March 31, 2018
	As Restated			Adjustments			As Previously Reported
Net loss	$	(7,737,791	)	$	(4,410,334	)	$	(3,327,457	)
Depreciation and amortization		358,986			(46,494	)		432,480
Unrealized (gain)/loss on fair value and derivative liabilities		1,926,013			4,234,195			(2,308,182	)
Prepaid expenses and other current assets		(243,619	)		204,290			(447,909	)
Accounts payable and accrued expenses		3,400,113			18,343			3,418,456